wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q34570079-7FD82CA3-BD74-49DC-A7FF-BD56AE39106A
Q34570079-7FD82CA3-BD74-49DC-A7FF-BD56AE39106A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34570079-7FD82CA3-BD74-49DC-A7FF-BD56AE39106A
Antibody-based therapeutics to watch in 2011.
P2860
Q34570079-7FD82CA3-BD74-49DC-A7FF-BD56AE39106A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34570079-7FD82CA3-BD74-49DC-A7FF-BD56AE39106A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
55cb65b690ad0b252c1d38e3d1fc7f30b2a45235
P2860
Phase 1 study of AMG 386, a selective angiopoietin 1/2-neutralizing peptibody, in combination with chemotherapy in adults with advanced solid tumors.